Valuation: AFT Pharmaceuticals Limited

Market Cap 451M 266M 230M 216M 197M 370M 25.47B 375M 2.53B 991M 12.76B 1B 979M 42.45B P/E 2027 *
22.9x
P/E 2028 * 18.2x
Enterprise Value 481M 284M 245M 230M 210M 394M 27.16B 399M 2.7B 1.06B 13.61B 1.07B 1.04B 45.26B EV / Sales 2027 *
1.58x
EV / Sales 2028 * 1.38x
Free-Float
22.37%
Yield 2027 *
0.76%
Yield 2028 * 0.97%
1 day-2.27%
1 week-6.52%
Current month-10.60%
1 month+9.97%
3 months+23.21%
6 months+19.44%
Current year+27.22%
1 week 4.3
Extreme 4.3
4.55
1 month 3.91
Extreme 3.91
4.85
Current year 3.35
Extreme 3.35
4.85
1 year 2.56
Extreme 2.56
4.85
3 years 2.37
Extreme 2.37
4.85
5 years 2.37
Extreme 2.37
5
10 years 1.7
Extreme 1.7
5.65
Manager TitleAgeSince
Human Resources Officer - 2012-09-03
Chief Executive Officer - 1997-09-03
Director of Finance/CFO - 2026-06-14
Director TitleAgeSince
Chairman - 2015-06-21
Director/Board Member - 1997-09-03
Director/Board Member - 2012-09-03
Date Insider Type Main position Quantity % Market Cap.
7/3/25 Buy

Founder

200,000 0.1907%
6/26/25 Free

Founder

17,755 0.0169%
12/2/24 Buy

Founder

45 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%-6.52%+67.97%+22.51% 266M
+0.25%-3.96%+68.73%+120.06% 1,055B
+0.78%+0.21%+48.53%+50.78% 632B
+0.35%+0.95%+21.11%+66.86% 442B
+0.28%-4.56%+39.10%+38.05% 351B
+0.78%-2.68%+24.03%+37.32% 290B
+0.87%-3.59%-0.28%+7.12% 243B
+1.00%+0.52%+41.46%+58.95% 227B
-0.78%-4.49%-10.28%-54.13% 200B
+0.40%+4.40%+17.36%+81.59% 172B
Average +0.17%-1.81%+31.77%+42.91% 361.28B
Weighted average by Cap. +0.44%-1.87%+39.71%+63.88%

Financials

2027 *2028 *
Net sales 304M 179M 155M 145M 132M 249M 17.16B 252M 1.7B 668M 8.6B 674M 659M 28.6B 345M 204M 176M 165M 150M 283M 19.5B 287M 1.94B 759M 9.77B 766M 749M 32.5B
Net income 19.7M 11.64M 10.05M 9.42M 8.58M 16.14M 1.11B 16.36M 110M 43.29M 557M 43.69M 42.74M 1.85B 24.81M 14.66M 12.66M 11.87M 10.81M 20.33M 1.4B 20.62M 139M 54.54M 702M 55.04M 53.85M 2.34B
Net Debt 29.84M 17.63M 15.22M 14.28M 13M 24.45M 1.69B 24.79M 167M 65.58M 844M 66.18M 64.75M 2.81B 24.6M 14.53M 12.55M 11.77M 10.72M 20.16M 1.39B 20.44M 138M 54.07M 696M 54.56M 53.38M 2.32B
Logo AFT Pharmaceuticals Limited
AFT Pharmaceuticals Limited is a New Zealand-based multinational pharmaceutical company. The Company develops, markets, and distributes a portfolio of pharmaceutical products across a range of therapeutic categories, which are distributed across three pharmaceutical distribution channels: over the counter (OTC), prescription and hospital. Its product portfolio comprises both proprietary and in-licensed products, and includes patented, branded, and generic drugs. The Company develops and in-licenses products for sale by sales teams in Australia and New Zealand and in certain Southeast Asian markets, and out-licenses its products to local licensees and distributors in the rest of the world. Its products include A-Scabies, Allersoothe, Allersoothe Elixir, BecloClear, Candaderm, Coco-Scalp, Cromo-Fresh, Fenpaed, Fenpaed Double Strength, Ferro-Sachets, HYLO-FORTE, Itch-Soothe, Kiwisoothe, Lax-Tab, Loraclear, VitA-POS, and others.
Employees
126
Date Price Change Volume
26-08-17 NZ$4.300 -2.27% 8,824
26-08-14 NZ$4.400 -0.68% 21,830
26-08-13 NZ$4.430 -1.99% 3,377
26-08-12 NZ$4.520 -0.22% 589
26-08-11 NZ$4.530 -1.52% 11,298
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.300NZD
Average target price
4.650NZD
Spread / Average Target
+8.14%

Annual profits - Rate of surprise